Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Irritable Bowel Syndrome, January 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 102 articles:
HTML format


 

Single Articles

  1. HOGESTOL IK, Chahal-Kummen M, Eribe I, Brunborg C, et al
    Chronic Abdominal Pain and Symptoms 5 Years After Gastric Bypass for Morbid Obesity.
    Obes Surg. 2016 Dec 27. doi: 10.1007/s11695-016-2499.
    Abstract    

    Abstract available

  2. YAZDANI M, Aramesh A, Rafiei R, Daghaghzadeh H, et al
    The comparison of treatments with and without azithromycin in irritable bowel syndrome with diarrhea-predominant in gastrointestinal Clinic of Al-Zahra Hospital, Isfahan, Iran.
    Adv Biomed Res. 2016;5:188.
    Abstract    

    Abstract available

  3. ROOHAFZA H, Bidaki EZ, Hasanzadeh-Keshteli A, Daghaghzade H, et al
    Anxiety, depression and distress among irritable bowel syndrome and their subtypes: An epidemiological population based study.
    Adv Biomed Res. 2016;5:183.
    Abstract    

    Abstract available

  4. PISCAGLIA AC, Laterza L, Cesario V, Gerardi V, et al
    Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?
    World J Gastroenterol. 2016;22:10198-10209.
    Abstract    

    Abstract available

  5. NAVARRO F, Liu Y, Rhoads JM
    Can probiotics benefit children with autism spectrum disorders?
    World J Gastroenterol. 2016;22:10093-10102.
    Abstract    

    Abstract available

  6. MEARIN F, Ciriza C, Minguez M, Rey E, et al
    [Clinical practice guidelines: Irritable bowel syndrome with constipation and functional constipation in adults: Concept, diagnosis, and healthcare continuity. (Part 1 of 2)].
    Aten Primaria. 2016 Dec 24. pii: S0212-6567(16)30455.
    Abstract    

    Abstract available

  7. BOECKXSTAENS GE, Wouters MM
    Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome.
    Neurogastroenterol Motil. 2016 Dec 27. doi: 10.1111/nmo.13007.
    Abstract    

    Abstract available

  8. GUARINO MP, Cicala M, Putignani L, Severi C, et al
    Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota.
    World J Gastroenterol. 2016;22:9871-9879.
    Abstract    

    Abstract available

  9. BAUMGARTNER C, Hubacher T, Krayer M, Gschossmann J, et al
    In vitro Spontaneous Contractile Activity of Colonic Smooth Muscle in Naive Lewis Rats: Acute Effect of Gonadal Hormones.
    J Dig Dis. 2016 Dec 23. doi: 10.1111/1751-2980.12438.
    Abstract    

    Abstract available

  10. OUWEHAND AC
    A review of dose-responses of probiotics in human studies.
    Benef Microbes. 2016 Dec 23:1-10. doi: 10.3920/BM2016.0140.
    Abstract    

    Abstract available

  11. REED DE, Vanner SJ
    Emerging Studies of Human Visceral Nociceptors.
    Am J Physiol Gastrointest Liver Physiol. 2016 Dec 22:ajpgi.00391.2016.
    Abstract    

    Abstract available

  12. CAMARA-LEMARROY CR, Diaz-Torres MA
    Reply to "Prevalence and impact of irritable bowel syndrome in people with epilepsy: Methodological issues".
    Epilepsy Behav. 2016 Dec 19. pii: S1525-5050(16)30706.
    Abstract    



  13. KICH DM, Vincenzi A, Majolo F, Volken de Souza CF, et al
    Probiotic: effectiveness nutrition in cancer treatment and prevention.
    Nutr Hosp. 2016;33:1430-1437.
    Abstract    

    Abstract available

  14. FANG X
    [Application of Roman IIII( criteria in the diagnosis of chronic constipation].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2016;19:1321-1323.
    Abstract    

    Abstract available

  15. QI R, Liu C, Weng Y, Xu Q, et al
    Disturbed Interhemispheric Functional Connectivity Rather than Structural Connectivity in Irritable Bowel Syndrome.
    Front Mol Neurosci. 2016;9:141.
    Abstract    

    Abstract available

  16. LANGLOIS LD, Le Long E, Meleine M, Antor M, et al
    Acute sacral nerve stimulation reduces visceral mechanosensitivity in a cross-organ sensitization model.
    Neurogastroenterol Motil. 2016 Nov 7. doi: 10.1111/nmo.12987.
    Abstract    

    Abstract available

  17. ALBUSODA A, Barki N, Herregods T, Kamphuis JB, et al
    A fresh look at IBS-opportunities for systems medicine approaches.
    Neurogastroenterol Motil. 2016 Nov 7. doi: 10.1111/nmo.12989.
    Abstract    

    Abstract available

  18. FARRE R, Vicario M
    Abnormal Barrier Function in Gastrointestinal Disorders.
    Handb Exp Pharmacol. 2016.
    Abstract    

    Abstract available

  19. CAMILLERI M, Ford AC
    Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.
    Handb Exp Pharmacol. 2016.
    Abstract    

    Abstract available

  20. DOS SANTOS SJ, Whiteley MS
    Pelvic congestion syndrome masquerading as osteoarthritis of the hip.
    SAGE Open Med Case Rep. 2016;4:2050313X16683630.
    Abstract    

    Abstract available

  21. REBER SO, Slattery DA
    Editorial: Using Stress-Based Animal Models to Understand the Mechanisms Underlying Psychiatric and Somatic Disorders.
    Front Psychiatry. 2016;7:192.
    Abstract    



  22. MICHALAK A, Mosinska P, Fichna J
    Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer.
    Front Pharmacol. 2016;7:459.
    Abstract    

    Abstract available

  23. CAO DY, Bai G, Ji Y, Karpowicz JM, et al
    EXPRESS: Histone hyperacetylation modulates spinal type II metabotropic glutamate receptor alleviating stress-induced visceral hypersensitivity in female rats.
    Mol Pain. 2016;12.
    Abstract    

    Abstract available

  24. ASANO T, Tanaka KI, Tada A, Shimamura H, et al
    Aminophylline suppresses stress-induced visceral hypersensitivity and defecation in irritable bowel syndrome.
    Sci Rep. 2017;7:40214.
    Abstract    

    Abstract available

  25. ABEY SK, Yuana Y, Joseph PV, Kenea ND, et al
    Lysozyme association with circulating RNA, extracellular vesicles, and chronic stress.
    BBA Clin. 2016;7:23-35.
    Abstract    

    Abstract available

  26. DOMZAL-MAGROWSKA D, Kowalski MK, Szczesniak P, Bulska M, et al
    The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes.
    Prz Gastroenterol. 2016;11:276-281.
    Abstract    

    Abstract available

  27. PERVEEN I, Parvin R, Saha M, Bari MS, et al
    Prevalence of Irritable Bowel Syndrome (IBS), Migraine and Co-Existing IBS-Migraine in Medical Students.
    J Clin Diagn Res. 2016;10:OC09-OC13.
    Abstract    

    Abstract available

  28. RIZZI A, Nucera E, Laterza L, Gaetani E, et al
    Irritable Bowel Syndrome and Nickel Allergy: What Is the Role of the Low Nickel Diet?
    J Neurogastroenterol Motil. 2017;23:101-108.
    Abstract    

    Abstract available

  29. LEE HJ, Choi JK, Ryu HS, Choi CH, et al
    Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders.
    J Neurogastroenterol Motil. 2017;23:9-19.
    Abstract    

    Abstract available

  30. RODRIGUEZ-FANDINO OA, Hernandez-Ruiz J, Lopez-Vidal Y, Charua-Guindic L, et al
    Maturation Phenotype of Peripheral Blood Monocyte/Macrophage After Stimulation with Lipopolysaccharides in Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2017 Jan 2. doi: 10.5056/jnm16137.
    Abstract    

    Abstract available

  31. BAI T, Li Y, Xia J, Jiang Y, et al
    Piezo2: A Candidate Biomarker for Visceral Hypersensitivity in Irritable Bowel Syndrome?
    J Neurogastroenterol Motil. 2017 Jan 2. doi: 10.5056/jnm16114.
    Abstract    

    Abstract available

  32. CANON M, Ruiz AJ, Rondon M, Alvarado J, et al
    Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic survey.
    Ann Gastroenterol. 2017;30:67-75.
    Abstract    

    Abstract available

  33. TSIAKIRIS G, Neely G, Lind N, Nordin S, et al
    Comorbidity in allergic asthma and allergic rhinitis: functional somatic syndromes.
    Psychol Health Med. 2016 Dec 30:1-6. doi: 10.1080/13548506.2016.1276606.
    Abstract    

    Abstract available

  34. VIDEHULT FK, West CE
    Nutrition, gut microbiota and child health outcomes.
    Curr Opin Clin Nutr Metab Care. 2016;19:208-13.
    Abstract    

    Abstract available

  35. BECKERS AB, Keszthelyi D, Fikree A, Vork L, et al
    Gastrointestinal disorders in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type: a review for the gastroenterologist.
    Neurogastroenterol Motil. 2017 Jan 13. doi: 10.1111/nmo.13013.
    Abstract    

    Abstract available

  36. SHABANZADEH DM, Sorensen LT, Jorgensen T
    Which Abdominal Symptoms are Associated with Clinical Events in a Population Unaware of Their Gallstones? a Cohort Study.
    J Gastrointest Surg. 2017 Jan 12. doi: 10.1007/s11605-016-3349.
    Abstract    

    Abstract available

  37. REY E, Mearin F, Alcedo J, Ciriza C, et al
    Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report.
    Adv Ther. 2017 Jan 12. doi: 10.1007/s12325-016-0473.
    Abstract    

    Abstract available

  38. LYRA A, Hillila M, Huttunen T, Mannikko S, et al
    Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
    World J Gastroenterol. 2016;22:10631-10642.
    Abstract    

    Abstract available

  39. YANG C, Xiong Y, Zhang SS, An FM, et al
    Regulating effect of TongXie-YaoFang on colonic epithelial secretion via Cl- and HCO3- channel.
    World J Gastroenterol. 2016;22:10584-10591.
    Abstract    

    Abstract available

  40. QIN X
    Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001010.
    Abstract    



  41. CREMON C, Bellacosa L, Barbaro MR, Cogliandro RF, et al
    The diagnostic challenge of symptomatic uncomplicated diverticular disease.
    Minerva Gastroenterol Dietol. 2017 Jan 12. doi: 10.23736/S1121-421X.17.02370.
    Abstract    

    Abstract available

  42. AJDACIC-GROSS V, Aleksandrowicz A, Rodgers S, Mutsch M, et al
    Infectious, atopic and inflammatory diseases, childhood adversities and familial aggregation are independently associated with the risk for mental disorders: Results from a large Swiss epidemiological study.
    World J Psychiatry. 2016;6:419-430.
    Abstract    

    Abstract available

  43. CHEN MX, Chen Y, Fu R, Liu SY, et al
    Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats.
    Am J Transl Res. 2016;8:5580-5590.
    Abstract    

    Abstract available

  44. SHEEN PA, Zahid MS, Fagbemi A, Fullwood C, et al
    'Holiday sickness'-reported exploratory outcome of over 500 United Kingdom holidaymakers with travellers' diarrhoea.
    J Travel Med. 2017;24.
    Abstract    

    Abstract available

  45. SCHOENFELD PS
    Advances in IBS 2016: A Review of Current and Emerging Data.
    Gastroenterol Hepatol (N Y). 2016;12.
    Abstract    

    Abstract available

  46. GERVASONI J, Schiattarella A, Giorgio V, Primiano A, et al
    Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome.
    Dis Markers. 2016;2016:5340386.
    Abstract    

    Abstract available

  47. ROMIJN AR, Rucklidge JJ, Kuijer RG, Frampton C, et al
    A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression.
    Aust N Z J Psychiatry. 2017 Jan 1:4867416686694. doi: 10.1177/0004867416686694.
    Abstract    

    Abstract available

  48. DAHL WJ, Agro NC, Eliasson AM, Mialki KL, et al
    Health Benefits of Fiber Fermentation.
    J Am Coll Nutr. 2017 Jan 9:1-10. doi: 10.1080/07315724.2016.1188737.
    Abstract    

    Abstract available

  49. BOUCHOUCHA M, Devroede G, Bon C, Bejou B, et al
    Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
    Tech Coloproctol. 2017 Jan 9. doi: 10.1007/s10151-016-1580.
    Abstract    

    Abstract available

  50. PELLISSIER S, Bonaz B
    The Place of Stress and Emotions in the Irritable Bowel Syndrome.
    Vitam Horm. 2017;103:327-354.
    Abstract    

    Abstract available

  51. FOURIE NH, Wang D, Abey SK, Creekmore AL, et al
    Structural and functional alterations in the colonic microbiome of the rat in a model of stress induced irritable bowel syndrome.
    Gut Microbes. 2017 Jan 6:0. doi: 10.1080/19490976.2016.1273999.
    Abstract    

    Abstract available

  52. AL-BAWARDY B, Sheedy SP, Herberts MB, Murray JA, et al
    Collagenous sprue cross-sectional imaging: a comparative blinded study.
    Abdom Radiol (NY). 2017 Jan 5. doi: 10.1007/s00261-016-1007.
    Abstract    

    Abstract available

  53. ZHANG F, Xiang W, Li CY, Li SC, et al
    Economic burden of irritable bowel syndrome in China.
    World J Gastroenterol. 2016;22:10450-10460.
    Abstract    

    Abstract available

  54. CEULEERS H, Van Spaendonk H, Hanning N, Heirbaut J, et al
    Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.
    World J Gastroenterol. 2016;22:10275-10286.
    Abstract    

    Abstract available

  55. FIROUZYAR T, Jalilian AR, Aboudzadeh MR, Sadeghpour H, et al
    Development of a radiolabeled amlodipine analog for L-type calcium channel imaging.
    Curr Radiopharm. 2017.
    Abstract    

    Abstract available

  56. EHMAN EC, Phelps AS, Ohliger MA, Rhee SJ, et al
    Detection of bowel inflammation with fused DWI/T2 images versus contrast-enhanced images in pediatric MR enterography with histopathologic correlation.
    Clin Imaging. 2016;40:1135-1139.
    Abstract    

    Abstract available

  57. BALLOU S, Keefer L
    Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases.
    Clin Transl Gastroenterol. 2017;8:e214.
    Abstract    

    Abstract available

  58. BRON PA, Kleerebezem M, Brummer RJ, Cani PD, et al
    Can probiotics modulate human disease by impacting intestinal barrier function?
    Br J Nutr. 2017 Jan 19:1-15. doi: 10.1017/S0007114516004037.
    Abstract    

    Abstract available

  59. ANDERSSON H, Tullberg C, Ahrne S, Hamberg K, et al
    Oral Administration of Lactobacillus plantarum 299v Reduces Cortisol Levels in Human Saliva during Examination Induced Stress: A Randomized, Double-Blind Controlled Trial.
    Int J Microbiol. 2016;2016:8469018.
    Abstract    

    Abstract available

  60. EDMAN JS, Greeson JM, Roberts RS, Kaufman AB, et al
    Perceived stress in patients with common gastrointestinal disorders: Associations with quality of life, symptoms, and disease management.
    Explore (NY). 2016 Dec 16. pii: S1550-8307(16)30234.
    Abstract    

    Abstract available

  61. KOPPEN IJ, Nurko S, Saps M, Di Lorenzo C, et al
    The pediatric Rome IV criteria: what's new?
    Expert Rev Gastroenterol Hepatol. 2017.
    Abstract    

    Abstract available

  62. ABDALLA MI, Sandler RS, Kappelman MD, Martin CF, et al
    Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001017.
    Abstract    

    Abstract available

  63. VISSIENNON C, Goos KH, Arnhold J, Nieber K, et al
    Mechanisms on spasmolytic and anti-inflammatory effects of a herbal medicinal product consisting of myrrh, chamomile flower, and coffee charcoal.
    Wien Med Wochenschr. 2017 Jan 13. doi: 10.1007/s10354-016-0538.
    Abstract    

    Abstract available

  64. SHKLYAEV AE, Pantyukhina AS, Gorbunov YV
    [The multifunctional therapy of various forms of irritable bowel syndrome].
    Vopr Kurortol Fizioter Lech Fiz Kult. 2016;93:37-40.
    Abstract    

    Abstract available

  65. BELLINI M, Usai-Satta P, Bove A, Bocchini R, et al
    Chronic constipation diagnosis and treatment evaluation: the "CHRO.CO.DI.T.E." study.
    BMC Gastroenterol. 2017;17:11.
    Abstract    

    Abstract available

  66. KHADEMVATAN S, Masjedizadeh R, Rahim F, Mahbodfar H, et al
    Blastocystis and irritable bowel syndrome: Frequency and subtypes from Iranian patients.
    Parasitol Int. 2017;66:142-145.
    Abstract    

    Abstract available

  67. JONES MP, Tack J, Van Oudenhove L, Walker MM, et al
    Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but not in the Population.
    Clin Gastroenterol Hepatol. 2017 Jan 10. pii: S1542-3565(17)30013.
    Abstract    

    Abstract available

  68. CAMILLERI M, Halawi H, Oduyebo I
    Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?
    Expert Rev Gastroenterol Hepatol. 2017.
    Abstract    

    Abstract available

  69. CAYZEELE-DECHERF A, Pelerin F, Leuillet S, Douillard B, et al
    Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis.
    World J Gastroenterol. 2017;23:336-344.
    Abstract    

    Abstract available

  70. ZAMUDIO-TIBURCIO A, Bermudez-Ruiz H, Lezama-Guzman HR, Guevara-Ortigoza MD, et al
    [Breaking paradigms. Intestinal microbiota transplantation: Preliminar report].
    Cir Cir. 2017 Jan 23. pii: S0009-7411(16)30145.
    Abstract    

    Abstract available

  71. NAITOU K, Shiina T, Nakamori H, Sano Y, et al
    Colokinetic effect of somatostatin in the spinal defecation center in rats.
    J Physiol Sci. 2017 Jan 25. doi: 10.1007/s12576-017-0524.
    Abstract    

    Abstract available

  72. BANNAGA A, Kelman L, O'Connor M, Pitchford C, et al
    How bad is bile acid diarrhoea: an online survey of patient-reported symptoms and outcomes.
    BMJ Open Gastroenterol. 2017;4:e000116.
    Abstract    

    Abstract available

  73. QIN Z, Li B, Wu J, Tian J, et al
    Acupuncture for chronic diarrhea in adults: Protocol for a systematic review.
    Medicine (Baltimore). 2017;96:e5952.
    Abstract    

    Abstract available

  74. CABRERA-CHAVEZ F, Dezar GV, Islas-Zamorano AP, Espinoza-Alderete JG, et al
    Prevalence of Self-Reported Gluten Sensitivity and Adherence to a Gluten-Free Diet in Argentinian Adult Population.
    Nutrients. 2017;9.
    Abstract    

    Abstract available

  75. LEE KN, Lee OY
    The Role of Mast Cells in Irritable Bowel Syndrome.
    Gastroenterol Res Pract. 2016;2016:2031480.
    Abstract    

    Abstract available

  76. WILLIAMS TE, Chalder T, Sharpe M, White PD, et al
    Heterogeneity in chronic fatigue syndrome - empirically defined subgroups from the PACE trial.
    Psychol Med. 2017 Jan 23:1-12. doi: 10.1017/S0033291716003615.
    Abstract    

    Abstract available

  77. PORTINCASA P, Bonfrate L, de Bari O, Lembo A, et al
    Irritable bowel syndrome and diet.
    Gastroenterol Rep (Oxf). 2017 Jan 20. pii: gow047. doi: 10.1093.
    Abstract    

    Abstract available

  78. PRAMANICK P, Chakraborty A, Raychaudhuri SS
    Phenotypic and biochemical alterations in relation to MT2 gene expression in Plantago ovata Forsk under zinc stress.
    Biometals. 2017 Jan 20. doi: 10.1007/s10534-017-9990.
    Abstract    

    Abstract available

  79. LI N, Tian H, Ma C, Ding C, et al
    [Efficacy analysis of fecal microbiota transplantation in the treatment of 406 cases with gastrointestinal disorders].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20:40-46.
    Abstract    

    Abstract available

  80. GALLOTTA S, Bruno V, Catapano S, Mobilio N, et al
    High risk of temporomandibular disorder in irritable bowel syndrome: Is there a correlation with greater illness severity?
    World J Gastroenterol. 2017;23:103-109.
    Abstract    

    Abstract available

  81. REN HX, Zhang FC, Luo HS, Zhang G, et al
    Role of mast cell-miR-490-5p in irritable bowel syndrome.
    World J Gastroenterol. 2017;23:93-102.
    Abstract    

    Abstract available

  82. VALDOVINOS MA, Montijo E, Abreu AT, Heller S, et al
    The Mexican consensus on probiotics in gastroenterology.
    Rev Gastroenterol Mex. 2017 Jan 16. pii: S0375-0906(16)30093.
    Abstract    

    Abstract available

  83. ROKANA N, Singh R, Mallappa RH, Batish VK, et al
    Modulation of intestinal barrier function to ameliorate Salmonella infection in mice by oral administration of fermented milks produced with Lactobacillus plantarum MTCC 5690 - a probiotic strain of Indian gut origin.
    J Med Microbiol. 2016;65:1482-1493.
    Abstract    

    Abstract available

  84. XU XJ, Yao SK
    Editorial: increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome. Authors' reply.
    Aliment Pharmacol Ther. 2017;45:568-569.
    Abstract    



  85. BENNET SM, Tornblom H
    Editorial: increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome.
    Aliment Pharmacol Ther. 2017;45:567-568.
    Abstract    



  86. SOOD R, Ford AC
    Editorial: volatile organic compounds in irritable bowel syndrome - technology for an accurate and reliable point-of-care test?
    Aliment Pharmacol Ther. 2017;45:563-564.
    Abstract    



  87. SOOD R, Gracie DJ, Gold MJ, To N, et al
    Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis.
    Aliment Pharmacol Ther. 2017 Jan 20. doi: 10.1111/apt.13949.
    Abstract    

    Abstract available

  88. CHANG BW, Rezaie A
    Irritable Bowel Syndrome-Like Symptoms Following Fecal Microbiota Transplantation: A Possible Donor-Dependent Complication.
    Am J Gastroenterol. 2017;112:186-187.
    Abstract    



  89. SAYUK GS, Wolf R, Chang L
    Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.
    Am J Gastroenterol. 2017 Jan 17. doi: 10.1038/ajg.2016.
    Abstract    

    Abstract available

  90. GUDLESKI GD, Satchidanand N, Dunlap LJ, Tahiliani V, et al
    Predictors of medical and mental health care use in patients with irritable bowel syndrome in the United States.
    Behav Res Ther. 2017;88:65-75.
    Abstract    

    Abstract available

  91. BHANDARI S, Venkatesan T
    Clinical Characteristics, Comorbidities and Hospital Outcomes in Hospitalizations with Cyclic Vomiting Syndrome: A Nationwide Analysis.
    Dig Dis Sci. 2017 Jan 3. doi: 10.1007/s10620-016-4432.
    Abstract    

    Abstract available

  92. HSU CS, Wen SH, Hung JS, Liu TT, et al
    Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics.
    Dig Dis Sci. 2017 Jan 23. doi: 10.1007/s10620-017-4455.
    Abstract    

    Abstract available

  93. MURAKAMI T, Kamada K, Mizushima K, Higashimura Y, et al
    Changes in Intestinal Motility and Gut Microbiota Composition in a Rat Stress Model.
    Digestion. 2017;95:55-60.
    Abstract    

    Abstract available

  94. MUJAGIC Z, Jonkers DM, Hungin AP, de Wit NJ, et al
    Use of Rome criteria for the diagnosis of irritable bowel syndrome in primary care: a survey among European countries.
    Eur J Gastroenterol Hepatol. 2017 Jan 25. doi: 10.1097/MEG.0000000000000848.
    Abstract    

    Abstract available

  95. KLEM F, Wadhwa A, Prokop L, Sundt W, et al
    Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: a Systematic Review and Meta-analysis.
    Gastroenterology. 2017 Jan 6. pii: S0016-5085(17)30008.
    Abstract    

    Abstract available

  96. MARTINEZ C, Rodino-Janeiro BK, Lobo B, Stanifer ML, et al
    miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea.
    Gut. 2017 Jan 12. pii: gutjnl-2016-311477. doi: 10.1136/gutjnl-2016-311477.
    Abstract    

    Abstract available

  97. ROLLAND-FOURCADE C, Denadai-Souza A, Cirillo C, Lopez C, et al
    Epithelial expression and function of trypsin-3 in irritable bowel syndrome.
    Gut. 2017 Jan 17. pii: gutjnl-2016-312094. doi: 10.1136/gutjnl-2016-312094.
    Abstract    

    Abstract available

  98. SIMREN M, Tornblom H, Palsson OS, van Tilburg MA, et al
    Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts.
    Gut. 2017 Jan 19. pii: gutjnl-2016-312361. doi: 10.1136/gutjnl-2016-312361.
    Abstract    

    Abstract available

  99. ALI A, Weiss TR, Dutton A, McKee D, et al
    Mindfulness-Based Stress Reduction for Adolescents with Functional Somatic Syndromes: A Pilot Cohort Study.
    J Pediatr. 2017 Jan 12. pii: S0022-3476(16)31548.
    Abstract    

    Abstract available

  100. GIANNETTI E, Maglione M, Sciorio E, Coppola V, et al
    Do Children Just Grow Out of Irritable Bowel Syndrome?
    J Pediatr. 2017 Jan 18. pii: S0022-3476(16)31435.
    Abstract    

    Abstract available

  101. NORLIN AK, Walter S, Theodorsson E, Tegelstrom V, et al
    Cortisol levels in hair are altered in irritable bowel syndrome - A case control study in primary care.
    J Psychosom Res. 2017;93:69-75.
    Abstract    

    Abstract available

  102. LEE SK, Yoon DW, Lee S, Kim J, et al
    The association between irritable bowel syndrome and the coexistence of depression and insomnia.
    J Psychosom Res. 2017;93:1-5.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;